Showing results (481-490 of 607) with videos related to

Sort By:
Pageof 61
Pharmacoeconomics - Open|April 11, 2023
Economic Evaluation Comparing Virtual Reality with Child Life Programming for Non-sedated Pediatric Medical Imaging: A Cost-Consequence AnalysisJohn Jacob, Chelsea Stunden, Dhayanand Deenadayalan, et al.
Pharmacoeconomics - Open|April 21, 2023
Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology AppraisalRachel Houten, Nigel Fleeman, James Mahon, et al.
Pharmacoeconomics - Open|May 2, 2023
Dealing with Time Estimates in Hospital Cost Accounting: Integrating Fuzzy Logic into Time-Driven Activity-Based CostingFiona Koster, Marc R Kok, Jaco van der Kooij, et al.
Pharmacoeconomics - Open|April 27, 2021
Short-Term Excess Healthcare Costs Associated with Cardiovascular Events Among Adults with Type 2 Diabetes in Israel: A Retrospective Cohort StudyCheli Melzer Cohen, Nino Hallén, Gabriel Chodick, et al.
Pharmacoeconomics - Open|April 8, 2021
Direct and Indirect Costs of Non-surgical Treatment for Acute Tonsillitis in Children in Southeast NigeriaMaduka Donatus Ughasoro, James Onuorah Akpeh, Nneamaka Echendu, et al.
Pharmacoeconomics - Open|May 13, 2023
Cost Effectiveness of Strategies for Caring for Critically Ill Patients with COVID-19 in TanzaniaHiral Anil Shah, Tim Baker, Carl Otto Schell, et al.
Pharmacoeconomics - Open|April 19, 2021
Impact of Letermovir Use for Cytomegalovirus Prophylaxis on Re-Hospitalization Following Allogeneic Hematopoietic Stem Cell Transplantation: An Analysis of a Phase III Randomized Clinical TrialYoav Golan, Yuexin Tang, Shahrul Mt-Isa, et al.
Pharmacoeconomics - Open|March 23, 2020
Cost-Effectiveness Analyses, Costs and Resource Use, and Health-Related Quality of Life in Patients with Follicular or Marginal Zone Lymphoma: Systematic ReviewsNeerav Monga, Jamie Garside, Binu Gurung, et al.
Pharmacoeconomics - Open|November 2, 2019
Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke PreventionItziar Oyagüez, Carmen Suárez, José Luis López-Sendón, et al.
Pharmacoeconomics - Open|February 15, 2020
Self-Monitoring and Management of Blood Pressure in Patients with Stroke or TIA: An Economic Evaluation of TEST-BP, A Randomised Controlled TrialLois G Kim, Edward C F Wilson, William J Davison, et al.
Pageof 61